Last 12 months
Inside the activity.
1 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 15, 2023 Filed Feb 17, 2023 20:43 UTC |
Gumbs Keir DCVP and Chief Legal Officer
|
GrantStock Option (Right to Buy) · Derivative | 18,001 | $0.00 Strike: $144.67 | $0.00 |
DisclosureSEC source: 0001225208-23-002235 · doc4.xml · derivative · entry 1 Gumbs Keir D · CIK 0001876435 · CVP and Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,001 Underlying: Common Stock · 18,001 shares Expires 2033-02-15 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 15, 2024. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 20:43 UTC |
DESCHUTTER DOUGLAS RICHARDCorporate Vice President
|
GrantStock Option (Right to Buy) · Derivative | 8,214 | $0.00 Strike: $144.67 | $0.00 |
DisclosureSEC source: 0001225208-23-002233 · doc4.xml · derivative · entry 2 DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Corporate Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,787 Underlying: Common Stock · 8,214 shares Expires 2033-02-15 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 15, 2024. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 20:43 UTC |
DESCHUTTER DOUGLAS RICHARDCorporate Vice President
|
GrantStock Option (Right to Buy) · Derivative | 28,573 | $0.00 Strike: $144.67 | $0.00 |
DisclosureSEC source: 0001225208-23-002233 · doc4.xml · derivative · entry 1 DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Corporate Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,573 Underlying: Common Stock · 28,573 shares Expires 2033-02-15 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 15, 2024. Read SEC document |
| January 31, 2023 Filed Feb 1, 2023 19:10 UTC |
Reese EdmundCorporate VP and CFO
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,721 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-001164 · doc4.xml · derivative · entry 4 Reese Edmund · CIK 0001833903 · Corporate VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,721 Underlying: Common Stock · 1,721 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represented one share of Broadridge common stock. On January 31, 2023, 1,721 Restricted Stock Units vested and converted into an equal number of shares of common stock. F2 · price: Each Restricted Stock Unit represented one share of Broadridge common stock. On January 31, 2023, 1,721 Restricted Stock Units vested and converted into an equal number of shares of common stock. F2 · derivative.expiration_date: Each Restricted Stock Unit represented one share of Broadridge common stock. On January 31, 2023, 1,721 Restricted Stock Units vested and converted into an equal number of shares of common stock. Read SEC document |
| January 31, 2023 Filed Feb 1, 2023 19:10 UTC |
Reese EdmundCorporate VP and CFO
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,721 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001225208-23-001164 · doc4.xml · derivative · entry 3 Reese Edmund · CIK 0001833903 · Corporate VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,721 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represented one share of Broadridge common stock. On January 31, 2023, 1,721 Restricted Stock Units vested and converted into an equal number of shares of common stock. F2 · price: Each Restricted Stock Unit represented one share of Broadridge common stock. On January 31, 2023, 1,721 Restricted Stock Units vested and converted into an equal number of shares of common stock. F2 · derivative.exercise_date: Each Restricted Stock Unit represented one share of Broadridge common stock. On January 31, 2023, 1,721 Restricted Stock Units vested and converted into an equal number of shares of common stock. F2 · derivative.expiration_date: Each Restricted Stock Unit represented one share of Broadridge common stock. On January 31, 2023, 1,721 Restricted Stock Units vested and converted into an equal number of shares of common stock. Read SEC document |
| January 31, 2023 Filed Feb 1, 2023 19:10 UTC |
Reese EdmundCorporate VP and CFO
|
Tax withholdingCommon Stock | 983 | $150.36 | $147,803.88 |
DisclosureSEC source: 0001225208-23-001164 · doc4.xml · nonDerivative · entry 2 Reese Edmund · CIK 0001833903 · Corporate VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,679.45 Read SEC document |
| January 31, 2023 Filed Feb 1, 2023 19:10 UTC |
Reese EdmundCorporate VP and CFO
|
Exercise / conversionCommon Stock | 1,721 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-001164 · doc4.xml · nonDerivative · entry 1 Reese Edmund · CIK 0001833903 · Corporate VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,662.45 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents one share of Broadridge common stock. On January 31, 2023, 1,721 Restricted Stock Units vested and converted into an equal number of shares of common stock. Read SEC document |
| January 05, 2023 Filed Jan 9, 2023 17:13 UTC |
Duelks Robert NDirector
|
GrantCommon Stock | 95 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-000479 · doc4.xml · nonDerivative · entry 1 Duelks Robert N · CIK 0001477044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,839 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| January 05, 2023 Filed Jan 9, 2023 12:14 UTC |
PERNA THOMAS JDirector
|
GrantCommon Stock | 95 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-000485 · doc4.xml · nonDerivative · entry 1 PERNA THOMAS J · CIK 0001209487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,799 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| January 05, 2023 Filed Jan 9, 2023 17:14 UTC |
FLOWERS MELVIN LDirector
|
GrantCommon Stock | 5 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-000480 · doc4.xml · nonDerivative · entry 1 FLOWERS MELVIN L · CIK 0001196490 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,123 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| January 05, 2023 Filed Jan 9, 2023 17:14 UTC |
keller brettDirector
|
GrantCommon Stock | 11 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-000481 · doc4.xml · nonDerivative · entry 2 KELLER BRETT · CIK 0001214608 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,502 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| January 05, 2023 Filed Jan 9, 2023 17:14 UTC |
keller brettDirector
|
GrantCommon Stock | 36 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-000481 · doc4.xml · nonDerivative · entry 1 KELLER BRETT · CIK 0001214608 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,491 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| January 05, 2023 Filed Jan 9, 2023 12:13 UTC |
BRUN LESLIE ADirector
|
GrantCommon Stock | 136 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-000477 · doc4.xml · nonDerivative · entry 1 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,813 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| January 05, 2023 Filed Jan 9, 2023 17:14 UTC |
MURRAY EILEEN KDirector
|
GrantCommon Stock | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-000483 · doc4.xml · nonDerivative · entry 1 MURRAY EILEEN K · CIK 0001341752 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 630 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| January 05, 2023 Filed Jan 9, 2023 17:14 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 12 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-000486 · doc4.xml · nonDerivative · entry 2 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,036 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| January 05, 2023 Filed Jan 9, 2023 17:14 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 12 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-000486 · doc4.xml · nonDerivative · entry 1 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,048 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| January 05, 2023 Filed Jan 9, 2023 17:14 UTC |
Nazareth Annette L.Director
|
GrantCommon Stock | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-000484 · doc4.xml · nonDerivative · entry 2 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,068 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| January 05, 2023 Filed Jan 9, 2023 17:14 UTC |
Nazareth Annette L.Director
|
GrantCommon Stock | 5 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-000484 · doc4.xml · nonDerivative · entry 1 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,065 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| January 05, 2023 Filed Jan 9, 2023 17:14 UTC |
Markus Maura A.Director
|
GrantCommon Stock | 16 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-000482 · doc4.xml · nonDerivative · entry 2 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,684.102 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| January 05, 2023 Filed Jan 9, 2023 17:14 UTC |
Markus Maura A.Director
|
GrantCommon Stock | 63 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-000482 · doc4.xml · nonDerivative · entry 1 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,668.102 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| January 05, 2023 Filed Jan 9, 2023 17:13 UTC |
Carter Pamela LDirector
|
GrantCommon Stock | 20 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-000478 · doc4.xml · nonDerivative · entry 1 Carter Pamela L · CIK 0001396958 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,002 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| December 19, 2022 Filed Dec 21, 2022 19:58 UTC |
keller brettDirector
|
GrantCommon Stock | 201 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-012944 · doc4.xml · nonDerivative · entry 1 KELLER BRETT · CIK 0001214608 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,455 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| December 19, 2022 Filed Dec 21, 2022 19:59 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 183 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-012947 · doc4.xml · nonDerivative · entry 1 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,024 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| December 19, 2022 Filed Dec 21, 2022 19:59 UTC |
Nazareth Annette L.Director
|
GrantCommon Stock | 201 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-012946 · doc4.xml · nonDerivative · entry 1 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,060 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| December 19, 2022 Filed Dec 21, 2022 19:58 UTC |
Markus Maura A.Director
|
GrantCommon Stock | 227 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-012945 · doc4.xml · nonDerivative · entry 1 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,605.102 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 11:27 UTC |
PERNA THOMAS JDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,753 | $0.00 Strike: $64.89 | $0.00 |
DisclosureSEC source: 0001225208-22-011864 · doc4.xml · derivative · entry 13 PERNA THOMAS J · CIK 0001209487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,753 shares Expires 2026-11-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 11:27 UTC |
PERNA THOMAS JDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,107 | $0.00 Strike: $88.66 | $0.00 |
DisclosureSEC source: 0001225208-22-011864 · doc4.xml · derivative · entry 12 PERNA THOMAS J · CIK 0001209487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,107 shares Expires 2027-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 11:27 UTC |
PERNA THOMAS JDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,469 | $0.00 Strike: $45.09 | $0.00 |
DisclosureSEC source: 0001225208-22-011864 · doc4.xml · derivative · entry 11 PERNA THOMAS J · CIK 0001209487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,469 shares Expires 2024-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 11:27 UTC |
PERNA THOMAS JDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,771 | $0.00 Strike: $56.37 | $0.00 |
DisclosureSEC source: 0001225208-22-011864 · doc4.xml · derivative · entry 10 PERNA THOMAS J · CIK 0001209487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,771 shares Expires 2025-11-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 11:27 UTC |
PERNA THOMAS JDirector
|
SaleCommon Stock | 27,480 | $147.83 | $4,062,236.50 |
DisclosureSEC source: 0001225208-22-011864 · doc4.xml · nonDerivative · entry 9 PERNA THOMAS J · CIK 0001209487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,704 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.46 - $148.62, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 11:27 UTC |
PERNA THOMAS JDirector
|
SaleCommon Stock | 4,227 | $147.09 | $621,737.59 |
DisclosureSEC source: 0001225208-22-011864 · doc4.xml · nonDerivative · entry 8 PERNA THOMAS J · CIK 0001209487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,184 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.00 - $147.42, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 11:27 UTC |
PERNA THOMAS JDirector
|
SaleCommon Stock | 3,992 | $147.09 | $587,172.10 |
DisclosureSEC source: 0001225208-22-011864 · doc4.xml · nonDerivative · entry 7 PERNA THOMAS J · CIK 0001209487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,411 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.00 - $147.42, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 11:27 UTC |
PERNA THOMAS JDirector
|
SaleCommon Stock | 3,426 | $147.09 | $503,920.75 |
DisclosureSEC source: 0001225208-22-011864 · doc4.xml · nonDerivative · entry 6 PERNA THOMAS J · CIK 0001209487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,403 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.00 - $147.42, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 11:27 UTC |
PERNA THOMAS JDirector
|
SaleCommon Stock | 3,292 | $147.09 | $484,211.06 |
DisclosureSEC source: 0001225208-22-011864 · doc4.xml · nonDerivative · entry 5 PERNA THOMAS J · CIK 0001209487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,829 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.00 - $147.42, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 11:27 UTC |
PERNA THOMAS JDirector
|
Exercise / conversionCommon Stock | 4,107 | $88.66 | $364,126.62 |
DisclosureSEC source: 0001225208-22-011864 · doc4.xml · nonDerivative · entry 4 PERNA THOMAS J · CIK 0001209487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,121 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 11:27 UTC |
PERNA THOMAS JDirector
|
Exercise / conversionCommon Stock | 4,753 | $64.89 | $308,422.17 |
DisclosureSEC source: 0001225208-22-011864 · doc4.xml · nonDerivative · entry 3 PERNA THOMAS J · CIK 0001209487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,014 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 11:27 UTC |
PERNA THOMAS JDirector
|
Exercise / conversionCommon Stock | 5,771 | $56.37 | $325,311.27 |
DisclosureSEC source: 0001225208-22-011864 · doc4.xml · nonDerivative · entry 2 PERNA THOMAS J · CIK 0001209487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,261 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 11:27 UTC |
PERNA THOMAS JDirector
|
Exercise / conversionCommon Stock | 6,469 | $45.09 | $291,687.21 |
DisclosureSEC source: 0001225208-22-011864 · doc4.xml · nonDerivative · entry 1 PERNA THOMAS J · CIK 0001209487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,490 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2022 Filed Nov 14, 2022 17:58 UTC |
Duelks Robert NDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,730 | $0.00 Strike: $133.74 | $0.00 |
DisclosureSEC source: 0001225208-22-011618 · doc4.xml · derivative · entry 3 Duelks Robert N · CIK 0001477044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,730 Underlying: Common Stock · 2,730 shares Expires 2032-11-09 F2 · derivative.exercise_date: Stock options vest immediately upon grant. Read SEC document |
| November 09, 2022 Filed Nov 14, 2022 17:58 UTC |
Duelks Robert NDirector
|
GrantCommon Stock | 627 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-011618 · doc4.xml · nonDerivative · entry 1 Duelks Robert N · CIK 0001477044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,744 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| November 09, 2022 Filed Nov 14, 2022 12:55 UTC |
BRUN LESLIE ADirector
|
GrantStock Option (Right to Buy) · Derivative | 3,602 | $0.00 Strike: $133.74 | $0.00 |
DisclosureSEC source: 0001225208-22-011616 · doc4.xml · derivative · entry 2 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,602 Underlying: Common Stock · 3,602 shares Expires 2032-11-09 F2 · derivative.exercise_date: Stock options vest immediately upon grant. Read SEC document |
| November 09, 2022 Filed Nov 14, 2022 12:55 UTC |
BRUN LESLIE ADirector
|
GrantCommon Stock | 827 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-011616 · doc4.xml · nonDerivative · entry 1 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,677 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| November 09, 2022 Filed Nov 14, 2022 12:59 UTC |
PERNA THOMAS JDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,730 | $0.00 Strike: $133.74 | $0.00 |
DisclosureSEC source: 0001225208-22-011623 · doc4.xml · derivative · entry 2 PERNA THOMAS J · CIK 0001209487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,730 Underlying: Common Stock · 2,730 shares Expires 2032-11-09 F2 · derivative.exercise_date: Stock options vest immediately upon grant. Read SEC document |
| November 09, 2022 Filed Nov 14, 2022 12:59 UTC |
PERNA THOMAS JDirector
|
GrantCommon Stock | 627 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-011623 · doc4.xml · nonDerivative · entry 1 PERNA THOMAS J · CIK 0001209487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,021 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| November 09, 2022 Filed Nov 14, 2022 18:01 UTC |
FLOWERS MELVIN LDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,730 | $0.00 Strike: $133.74 | $0.00 |
DisclosureSEC source: 0001225208-22-011619 · doc4.xml · derivative · entry 2 FLOWERS MELVIN L · CIK 0001196490 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,730 Underlying: Common Stock · 2,730 shares Expires 2032-11-09 F2 · derivative.exercise_date: Stock options vest immediately upon grant. Read SEC document |
| November 09, 2022 Filed Nov 14, 2022 18:01 UTC |
FLOWERS MELVIN LDirector
|
GrantCommon Stock | 627 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-011619 · doc4.xml · nonDerivative · entry 1 FLOWERS MELVIN L · CIK 0001196490 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,118 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| November 09, 2022 Filed Nov 14, 2022 18:02 UTC |
keller brettDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,730 | $0.00 Strike: $133.74 | $0.00 |
DisclosureSEC source: 0001225208-22-011620 · doc4.xml · derivative · entry 2 KELLER BRETT · CIK 0001214608 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,730 Underlying: Common Stock · 2,730 shares Expires 2032-11-09 F2 · derivative.exercise_date: Stock options vest immediately upon grant. Read SEC document |
| November 09, 2022 Filed Nov 14, 2022 18:02 UTC |
keller brettDirector
|
GrantCommon Stock | 627 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-011620 · doc4.xml · nonDerivative · entry 1 KELLER BRETT · CIK 0001214608 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,254 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| November 09, 2022 Filed Nov 14, 2022 17:56 UTC |
MURRAY EILEEN KDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,730 | $0.00 Strike: $133.74 | $0.00 |
DisclosureSEC source: 0001225208-22-011625 · doc4.xml · derivative · entry 2 MURRAY EILEEN K · CIK 0001341752 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,730 Underlying: Common Stock · 2,730 shares Expires 2032-11-09 F2 · derivative.exercise_date: Stock options vest immediately upon grant. Read SEC document |
| November 09, 2022 Filed Nov 14, 2022 17:56 UTC |
MURRAY EILEEN KDirector
|
GrantCommon Stock | 627 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-011625 · doc4.xml · nonDerivative · entry 1 MURRAY EILEEN K · CIK 0001341752 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 627 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.